Latest "Biomarker discovery Driving technologies" News Stories

23:07 EDT 30th July 2015 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 6,300+


Integrating biomarkers in colorectal cancer trials in the West and China

Predictive biomarkers are invaluable for successful and cost-effective treatment of cancer, however, biomarker discovery is difficult and requires multiple independent studies to identify suitable predictors of efficacy. Clinical trials performed in ...

Medical News Today: Ovarian cancer treatment set to improve following biomarker discovery

The discovery of a biomarker that predicts the response to chemotherapy in patients with the most malignant form of ovarian cancer will help lead to better treatment options.

Biomarker Summit Europe 2015 on October 5-8, 2015 in Berlin, Germany

The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of ...

Potential Biomarker Discovered for Lung Cancer

To date, no biomarker has been found for lung cancer. This discovery could help quick and cost-effective diagnosis at an earlier stage of the disease, improving survival rates.

Biomarker discovery offers clearer prognosis for bowel and rectal cancer patients

For the first time, a biomarker discovered by Macquarie University and Concord Repatriation General Hospital researchers will allow clinicians to distinguish certain types of colorectal cancer patients who do relatively well after surgery from those ...

Medical News Today: Lung cancer blood test steps closer with new biomarker discovery

Researchers have discovered a blood biomarker that is 'highly effective' in distinguishing between people with and without nonsmall cell lung cancer.

Denovo Biomarkers: Robert Little. Providing a novel biomarker solution to personalize drug development

Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.

Alternative splicing as a biomarker and potential target for drug discovery

Blood test for osteoarthritis on the cards thanks to new discovery

The first blood test for osteoarthritis could soon be available following the discovery of a biomarker linked to both rheumatoid and osteoarthritis. The findings could lead to people being tested for osteoarthritis and diagnosed several years before the onset of physical symptoms. Citrullinated proteins (CPs) are the focus of the research. We already know that […] The post Blood test for ost...

Berg: Using artificial intelligence for drug discovery

Berg, a Boston biotech, has a strong artificial intelligence platform for drug discovery. It has several drugs in its pipeline, and is leading an effort to discover the very first biomarker for pancreatic cancer.

Transgenomic – genetic biomarker identification

Transgenomic is a biotech company identifying genetic biomarker using proprietary methods and assays. Transgenomic – genetic biomarker identification Transgenomic is advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies. This biotech company is a global … Continue reading → Cet article Transgenomic – g...

Epistem announces collaboration with Sanofi Aventis

Epistem plc, the UK biotechnology and personalised medicine company today announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's proprietary biomarker gene expression profiling and immunohistochemistry technologies. ...

CheckMate-057 Trial: The Future of PD-L1 as a Biomarker

Dr H. Jack West discusses one of the hottest topics at ASCO 2015: the evolving role of PD-L1 as an immunotherapy biomarker. Medscape Oncology

Driving customer centricity at headquarters through defining and driving the right KPIs

At last years DigiPharm 2014 event,  Debraj Dasgupta , Team Leader – Oncology, Metabolism, Immunology, Boehringer Ingelheim GmbH,  gave the presentation “Driving customer centricity at headquarters through ... The post Driving customer centricity at headquarters through defining and driving the right KPIs appeared first on Total Biopharma.

Alexion, Blueprint to develop, market rare genetic disease treatments

Blueprint Medicines is partnering with Alexion to use its kinase-focused drug-discovery technology to research, develop and m -More- Biomarkers Summit 2015 Register for the Biomarkers Summit 2015 on March 18-20, 2015 in San Diego, CA. Meet ...

New immunoregulation and biomarker

Clinicians at LMU have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.

Aptagen – aptamer-beacon

Aptagen is a biotech company proposing aptamer products and services as reagents, diagnostic and biomarker discovery tools. Aptamers are used in drug discovery, targeted delivery for therapeutics or bioindustrial applications. Aptagen – aptamer-beacon Aptamers (synthetic antibodies) are ligands of RNA, … Continue reading → Cet article Aptagen – aptamer-beacon est apparu en ...

Amarantus and Anavex in AD biomarker collaboration

Amarantus BioScience Holdings (OTCQB:AMBS) and Anavex Life Sciences (OTCQX:AVXL) have signed a biomarker services agreement in which Amarantus will evaluate the pharmacodynamic effect of ANAVEX 2-73 and ANAVEX PLUS on the expression of the biomarker CD69 in specific sub-populations of peripheral blood lymphocytes, using Amarantus’ proprietary Alzheimer’s blood diagnostic LymPro Test. T...

Potential Biomarker for Alzheimer’s Found

Current tests for Alzhemier's disease are costly and inefficient. Scientists may have found a blood biomarker that could be used to test more people who are at-risk of developing the condition.

Retrospective Sample Collection for Biomarker Discovery, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - March 17, 2015) - Join speakers from Almac Diagnostics, including Dr. Peter Kerr, Head of Project Management & Product Development, and Kinga Wojciechowska, Project Manager for Ethics/Tissue Collection, as they discuss sample access and profiling for biomarker discovery to help rescue or reposition drugs. The complimentary 60-minute broadcast takes place on Wednesda...

Discovery Life Sciences, Inc. introduces Magellan -- an Innovative WEB based Biobank delivering Human Biospecimens to advance Novel Biomarker tests in clinical development

LOS OSOS, Calif., July 14, 2015 /PRNewswire/ -- Discovery Life Sciences, Inc., a provider of essential clinical research products and services to the Life Sciences industry announced today that it has launched Magellan – an innovative online ordering platform for ready-to-deliver Human Biospecimens designed for Biopharmaceutical, Biotechnology and Medical Device companies who seek ...

SGS adds to biomarker analysis service

SGS Life Science Services, a clinical and bioanalytical contract group has invested in additional modules for its COBAS 6000 analysis system, to increase its biomarker analytical capabilities.

Spit-and-Stick Test Could Be Biomarker for HNSCC

A much-needed biomarker for head and neck squamous cell carcinoma (HNSCC) that assesses tumor DNA shed in plasma and saliva is in the works. Medscape Medical News

The AAPS Journal: Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation

Type: Original PaperIt is often necessary to adjust for detectable endogenous biomarker levels in spiked validation samples (VS) and in selectivity determinations during bioanalytical method validation for ligand-binding assays (LBA) with a matrix li...

Teen texting and driving dips with state laws

(Reuters Health) - According to a new analysis of nationwide surveys, teens report less texting while driving in the years following statewide bans. But texting while driving rates are still high, the researchers found.


News Quicklinks